PTCL-NOS

Clinical trials for PTCL-NOS explained in plain language.

Never miss a new study

Get alerted when new PTCL-NOS trials appear

Sign up with your email to follow new studies for PTCL-NOS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

Can a Two-Drug combo outsmart Hard-to-Treat lymphoma?

Disease control Not yet recruiting

This early-phase trial is testing whether the experimental drug zeprumetostat, which blocks a protein called EZH2, can work together with either another targeted drug (golidocitinib) or a standard chemotherapy regimen (GemOx) to shrink tumors in people with a rare and aggressive …

Matched conditions: PTCL-NOS

Phase: PHASE1, PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control

Last updated Jul 26, 2026 00:00 UTC

PTCL-NOS

Get alerted when new PTCL-NOS trials appear

Can a Two-Drug combo outsmart Hard-to-Treat lymphoma?